Navigation Links
PDI Reports 2013 First Quarter Financial Results
Date:5/13/2013

ecisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. These statements also involve known and unknown risks, uncertainties and other factors that may cause PDI's actual results to be materially different from those expressed or implied by any forward-looking statement. For example, with respect to statements regarding projections of future revenues, growth and profitability, actual results may differ materially from those set forth in this release based on the loss, early termination or significant reduction of any of our existing service contracts, the failure to meet performance goals in PDI's incentive-based arrangements with customers or the inability to secure additional business. Additionally, all forward-looking statements are subject to the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2012, and PDI's subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

(Tables to Follow)PDI, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)(in thousands, except per share data)Three Months EndedMarch 31,20132012Revenue, net

$
42,923$
31,677Cost of services

34,45024,311Gross profit

8,4737,366Compensation expense

4,1554,582Other selling, general and administrative expenses

2,0653,005Total operating expenses

6,2207,587Operating income (loss)

2,253(221)Other expense, net

(9)(1)Inc
'/>"/>

SOURCE PDI, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  On May ... will convene in Santa Monica, CA ... on Lung-Sparing Therapies for Malignant Pleural Mesothelioma (MPM), ... exposure to asbestos and commonly affects the lining ... co-hosted by UCLA and the Pacific Mesothelioma Center ...
(Date:3/31/2015)... Columbia , March 31, 2015  InMed ... clinical stage biopharmaceutical company that specializes in developing ... appointment of Paul C. Anderson , Ph.D., ... a pharma industry veteran who brings significant drug ... Dr. Anderson is a synthetic organic chemist by ...
(Date:3/31/2015)...   Unique Pharmaceuticals , a 503B outsourcing facility, ... company has initiated sterile compounding operations meeting the newly ... company is to meet and exceed industry standards," said ... new regulations is validation of our quality management system ... our industry, investing in its continued success and are ...
Breaking Medicine Technology:Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
... , PRINCETON, N.J. , Jan. ... a global healthcare company, announced today the U.S. Food and ... (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 ... is indicated as an adjunct to diet and exercise to ...
... , , MOUNTAIN VIEW, Calif. , Jan. 25 ... US study for the ArterX Vascular Sealant™. The study was ... to receive a synthetic vascular graft or patch at 12 ... of arteriovenous dialysis access grafts, carotid endarterectomy patches and large ...
Cached Medicine Technology:Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes 2Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes 3Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes 4Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes 5Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes 6Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study 2
(Date:3/31/2015)... Former 49ers linebacker Chris Borland turned more heads with ... a promising NFL career. In a March episode of ... Leitch explores the curious case of Borland and the ... making process that Borland and other football players will likely ... paycheck, and what impact, if any, he thinks this case ...
(Date:3/31/2015)... National Adaptive Sports Month will ... benefits of participating in adaptive sports activities, educate ... athletes that adapt, believe and compete each week ... fitness and inclusive athletics in our schools, provide ... sports and advocate for an increase in the ...
(Date:3/31/2015)... Purchase, NY (PRWEB) March 31, 2015 ... to announce the presentation of new clinical study ... bonded arginine silicate (ASI), titled, “Arginine Silicate Supplementation ... and Increases Markers of Vasodilation and Cardiovascular Health ... to scientists and other professionals at the acclaimed ...
(Date:3/31/2015)... The New Jersey Chapter of the ... two administrators from Windsor Healthcare Communities, a leading ... Jersey, to two key leadership roles at this ... administrator for Abingdon Care & Rehabilitation Center of ... administrator of Canterbury Care & Rehabilitation Center at ...
(Date:3/31/2015)... 31, 2015 Williams Comfort Air ... visit when their home comfort is at stake. ... the visit fit into the customer’s schedule, a ... quality repair at requested times. , To ... customers in the Indianapolis area can visit ...
Breaking Medicine News(10 mins):Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 2Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 4Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 5Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 6Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2
... (NYSE: HB ) today announced its fiscal 2008 ... declared by Hillenbrand,s,Board of Directors on February 7, 2008, ... record at the close of business on March 17, ... is organized into two operating companies,serving the health care ...
... 6 times more likely to make mistakes , , FRIDAY, ... are about six times more likely to make medication errors ... a 123 pediatric residents at three children,s hospitals in the ... residents were depressed, and 74 percent were burned out. During ...
... CJPS Enterprises, LLC, (http://www.cjps-enterprises.com ) announced that it ... and licensing of intellectual property (IP)., The ... already,making its website available to universities, research organizations, ... "You have,to fill the shelves of the store ...
... Oversee Phase 3 Program of CGT-2168, ... Pharmaceuticals,Inc., today named a distinguished international panel ... Steering Committee charged with overseeing COGENT,the company,s ... its novel,combination antiplatelet product CGT-2168., (Logo: ...
... Mylan Inc. (NYSE: MYL ),today announced that Mylan ... judge in Florida finding that the inclusion of,Levothyroxine Sodium ... of legislative authority and that the product should be ... products available to pharmacies in Florida as soon,as motions ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), a ... it will host an investor,conference call on Friday, ... to,discuss the recently announced signing of a definitive ... (along with its,subsidiaries, "CHS"). Hosting the call from ...
Cached Medicine News:Health News:Depression in Young Doctors Tied to Medication Errors 2Health News:CJPS Enterprises Spins Off New Company for Intellectual Property Marketing 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 3Health News:Mylan Restores Availability of Generic Levothyroxine in Florida 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4
... deliver unmatched performance through patient-focused care. , ... complete anesthesia solution developed, putting patient-focused care ... your fingertips., ,The Aisys Carestation is ... anesthesia delivery and patient monitoring technology. We ...
... LP is a super-light polypropylene mesh which ... reaction is reduced considerably. Optilene Mesh LP ... open hernia repair procedures. It perfectly conforms,to ... Optilene Mesh LP adapts to the movements ...
... a lightweight and large pore polypropylene mesh. Due ... to adapt to all movements taking place in ... with the large pores enables for idealhealing and ... ideal for incisional hernia repair and can also ...
... Premilene Mesh LP is a lightweight ... bicompatibility and considerably reduced,foreign body reaction. ... and pain. It perfectly conforms to,anatomical ... Premilene Mesh LP adapts to the ...
Medicine Products: